Free access to an expert-led, practical and evidence-based tool designed to help you to provide optimal management of type 2 diabetes with glucagon-like peptide-1 receptor agonists (GLP-1RAs). Guided by internationally renowned diabetes researcher Professor Melanie...
Each year PCDE issues a research grant for research projects in Primary Care. The submissions were competitive this year and each of them would have been a worthy winner. The PCDE board would like to thank everyone who submitted a proposal, for their contribution...
EURADIA is undertaking a survey to highlight the impact of the Covid-19 pandemic on research funding. There is already evidence of Diabetes research being impacted – despite an increased threat to health from Covid-19 for people with Diabetes. We are...
Benefits and harms of sodium-glucose co-transporter-2 inhibitors (SGLT2-I) and renin–angiotensin–aldosterone system inhibitors (RAAS-I) versus SGLT2-Is alone in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.Samuel...
IT TAKES MORE THAN JUST A REGISTRY TO IMPROVE CARE: HOW CAN WE USE DATA TO RAISE AWARENESS AND INITIATE ACTION TO IMPROVE OUTCOMES FOR PEOPLE WITH DIABETES? Welcome and introduction David Matthews, University of Oxford, vice-chair EUDF How can we use data to raise...
